Pharmaceutical services for endemic situations in the Brazilian Amazon: Organization of services and prescribing practices for Plasmodium vivax and Plasmodium falciparum non-complicated malaria in high-risk municipalities

Malaria Journal

Volumn 10, Issue , 2011, Pages

  Suárez Mutis, Martha C ^a   De Souza, Paula P ^a   Freitas, Letícia F ^a   Miranda, Elaine S ^b   Campos, Mônica R ^a   Osorio De Castro, Claudia Gs ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b FLUMINENSE FEDERAL UNIVERSITY   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT;

ARTICLE; BRAZIL; CONCEPTUAL FRAMEWORK; DRUG STORAGE; ENDEMIC DISEASE; ENVIRONMENT; HEALTH CARE FACILITY; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; ORGANIZATION; PHARMACY; PILOT STUDY; PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; PLASMODIUM VIVAX MALARIA; PRESCRIPTION; WORLD HEALTH ORGANIZATION; ADOLESCENT; ADULT; AGED; CITY; FEMALE; HEALTH SERVICES RESEARCH; INTERVIEW; MALE; MIDDLE AGED; ORGANIZATION AND MANAGEMENT; PRACTICE GUIDELINE; STATISTICS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIMALARIALS; BRAZIL; CITIES; FEMALE; GUIDELINE ADHERENCE; HEALTH SERVICES RESEARCH; HUMANS; INTERVIEWS AS TOPIC; MALARIA, FALCIPARUM; MALARIA, VIVAX; MALE; MIDDLE AGED; PHARMACEUTICAL SERVICES; PILOT PROJECTS; PRESCRIPTIONS; YOUNG ADULT;

EID: 84855454502     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-10-335     Document Type: Article

References (41)

1. Malaria in Brazil: an overview. Oliveira-Ferreira J, Lacerda MVG, Brasil P, Ladislau JLB, Tauil PL, Daniel-Ribeiro CT, Malar J 2010 9 115 10.1186/1475-2875-9-115 20433744
2. Controle da malária no Brasil: 1965 a 2001. Loiola CCP, da Silva CJM, Tauil PL, Pan Am J Public Health 2002 11 235 244 10.1590/S1020- 49892002000400005 (Pubitemid 34555773)
3. Malária. Ministério da Saúde (MS)/Secretaria de Vigilncia em Saúde (SVS), http://portal.saude.gov.br/portal/arquivos/doc/ apresentacao-malaria-site-az.ppt#835,1,Maláriaf.
4. Evidence-based public health and prospects for malaria control in Brazil. Ferreira MU, da Silva-Nunes M, J Infect Develop Countries 2010 4 533 45
5. Malária. Aspectos Epidemiolágicos 2011. Ministério da Saúde (MS)/Secretaria de Vigilncia em Saúde (SVS), http://portal.saude.gov.br/portal/saude/profissional/visualizar-texto.cfm?idtxt= 31086&janela=2
6. Chloroquine-resistant Plasmodium vivax, Brazilian Amazon. Santana-Filho FS, Arcanjo ARL, Costa MR, FE M-E, Vieira JL, Barbosa MGV, Alecrim WD, Alecrim MG, Emerg Infect Dis 2007 13 1125 1126 18214203 (Pubitemid 47048104)
7. Ravreda Ami Newsletter. http://www.paho.org/english/ad/dpc/cd/ravreda- ami-news4.pdf
8. MS (Ministério da Saúde), SVS (Secretaria de Vigilncia em Saúde), DVE (Departamento de Vigilncia Epidemiolágica), Guia prático de tratamento da malária no Brasil Brasília: Ministério da Saúde 2010
9. Programa Nacional de Prevenção e Controle da Malária-PNCM. Ministério da Saúde/Secretaria de Vigilncia em Saúde, Brasília: FUNASA 2003
10. Malária não-complicada por P. vivax e P. falciparum no Brasil: evidências sobre fármacos isolados e associaçes medicamentosas empregados em esquemas terapêuticos recomendados pelo protocolo terapêutico oficia. Freitas LF, Chaves GC, Wannmacher L, Osorio-de-Castro CGS, Cad Saúde Pública 2007 23 2285 2294 21914813
11. Perfil da assistência farmacêutica na atenção primária do Sistema nico de Saúde. Araujo ALA, Pereira LRL, Ueta JM, Freitas O, Cien Saude Colet 2008 13 supl 611 617 21936165
12. A proposal for an evaluation model of pharmaceutical services for malaria. Osorio-de-Castro CGS, Chaves GC, Ruiz AM, Miranda ES, Campos MR, Suárez-Mutis MC, Freitas LF, Cad Saúde Pública 2009 25 2075 2082 21914813
13. World Health Organization, Management Science for Health, How to investigate drug use in health facilities: Selected drug use indicators Geneva: WHO 1993
14. MSH/RPMP (Management Sciences for Health/Rational Pharmaceutical Management Project), Rapid pharmaceutical Management Assessment: an indicator based approach MSH 1995
15. Avaliação da assistência farmacêutica s pessoas vivendo com HIV/AIDS no município do Rio de Janeiro. Oliveira MA, Esher AFSC, Santos EM, Cosendey MA, Luiza VL, Bermudez JAZ, Cad Saúde Pública 2002 18 1429 1439 21914813
16. Clark M, Drug management for malaria manual Arlington: MSH (Management Science for Health) 2000
17. Fundação Nacional de Saúde/Ministério da Saúde, Manual de terapêutica da malária Brasília: Fundação Nacional de Saúde/Ministério da Saúde; 2001
18. Conhecimentos, práticas e percepçes de profissionais de saúde sobre o tratamento de malária não complicada em municípios de alto risco da Amazônia Legal. Osorio-de-Castro CGS, Miranda ES, Esher AFSC, Campos MR, Brasil JC, Ferreira ACS, Emmerick ICM, Cien Saude Colet 2011 16 1445 1456 21503496
19. Research influence on antimalarial drug policy change in Tanzania: case study of replacing chloroquine with sulfadoxine-pyrimethamine as the first-line drug. Mubyazi GM, Gonzalez-Block MA, Malar J 2005 4 51 10.1186/1475-2875-4-51 16242017 (Pubitemid 41597303)
20. Adherence and efficacy of supervised versus non-supervised treatment with artemether/lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Bangladesh: a randomised controlled trial. Rahman MM, Dondorp AM, Day NP, Lindegardh N, Imwong M, Faiz MA, Bangali AM, Kamal AT, Karim J, Kaewkungwal J, Singhasivanon P, Trans R Soc Trop Med Hyg 2008 102 861 867 10.1016/j.trstmh.2008.05.022 18606428
21. Avaliação pontual da qualidade de antimaláricos no Sistema nico de Saúde-SUS. Nogueira FHA, Belo Horizonte: Universidade Federal de Minas Gerais; Faculdade de Farmácia 2007
22. Health service providers in Somalia: their readiness to provide malaria case-management. Noor AM, Rage IA, Moonen B, Snow R, Malar J 2009 8 100 10.1186/1475-2875-8-100 19439097
23. Improving equity in malaria treatment: Relationship of socio-economic status with health seeking as well as with perceptions of ease of using the services of different providers for the treatment of malaria in Nigeria. Onwujekwe O, Uzochukwu B, Eze S, Obikeze E, Okoli C, Ochonma O, Malar J 2008 7 5 10.1186/1475-2875-7-5 18182095 (Pubitemid 351302475)
24. World Health Organization, World Malaria Report Geneva: WHO 2009
25. Antimalarial prescribing and dispensing practices in health centres of Khartoum State, 2003-04. Mannan AA, Malik EM, Ali KM, East Mediterr Health J 2009 15 122 128 19469434
26. Prescribing practice for malaria following introduction of artemether-lumefantrine in an urban area with declining endemicity in West Africa. Okebe JU, Walther B, Bojang K, Drammeh S, Schellenberg D, Conway DJ, Walther M, Malar J 2010 9 180 10.1186/1475-2875-9-180 20573266
27. Case management of malaria in under-fives at primary health care facilities in a Tanzanian district. Nsimba SE, Massele AY, Eriksen J, Gustafsson LL, Tomson G, Warsame M, Trop Med Int Health 2002 7 201 209 10.1046/j.1365-3156.2002.00847.x 11903982 (Pubitemid 34264372)
28. Towards a precise test for malaria diagnosis in the Brazilian Amazon: comparison among field microscopy, a rapid diagnostic test, nested PCR, and a computational expert system based on artificial neural networks. Andrade BB, Reis-Filho A, Barros AM, Souza-Neto SM, Nogueira LL, Fukutani KF, Camargo LMA, Barral A, Duarte A, Barral-Neto M, Malar J 2010 9 117 10.1186/1475-2875-9-117 20459613
29. Brasil, Portaria N°2.143, de 09 de outubro de 2008. Cria o incentivo financeiro referente inclusão do microscopista na atenção básica para realizar, prioritariamente, açes de controle da malária junto s Equipes de Agentes Comunitários de Saúde-EACS e/ou s Equipes de Saúde da Família E S F Brasília;, Ministério da Saúde/Gabinete do Ministro, 2008 21120327
30. Measurement of adherence, drug concentrations and the effectiveness of artemether-lumefantrine, chlorproguanil-dapsone or sulphadoxine-pyrimethamine in the treatment of uncomplicated malaria in Malawi. Bell DJ, Wotton D, Mukaka M, Montgomery J, Kayange N, Chimpeni P, Hughes DA, Molyneux ME, Ward SA, Winstanley PA, Lalloo DG, Malar J 2009 8 204 10.1186/1475-2875-8-204 19709418
31. Ministério da Saúde/Secretaria de Vigilncia em Saúde. http://portal.saude.gov.br/portal/arquivos/pdf/situacao-da- malaria-site-svs-28-12.pdf
32. Centro de Vigilncia Epidemiolágica/Superintendência de Controle de Endemias. http://www.sucen.sp.gov.br/downl/malaria/mal1.pdf
33. Adherence to antimalarial drug therapy among vivax malaria patients in northern Thailand. Khantikul N, Butraporn P, Kim HS, Leemingsawat S, Tempongko MA, Suwonkerd W, J Health Popul Nutr 2009 27 4 13 19248643
34. Drug therapy: Adherence to Medication. Osterberg LMD, Blaschke TMD, N Engl J Med 2005 353 487 497 10.1056/NEJMra050100 16079372 (Pubitemid 41127293)
35. Factors affecting therapeutic compliance: A rteview from the patien's perspective. Jin J, Sklar GE, Oh VMS, Li SC, Ther Clin Risk Manag 2008 4 1 18728698
36. Brasil, Portaria n.°44/GM, de 03 de janeiro de 2002. Estabelece as atribuiçes do agente comunitário de saúde na prevenção e controle da malária e da dengue Brasília; 2002 21120327
37. Ministério da Saúde/Programa Nacional de Controle da Tuberculose. http://portal.saude.gov.br/portal/saude/profissional/visualizar- texto.cfm?idtxt=31101
38. Can malaria be controlled where basic health services are not used? Unger JP, d'Alessandro U, De Paepe P, Green A, Trop Med Int Health 2006 2 314 322 (Pubitemid 43357054)
39. Millenium Development Goals. http://www.un.org/millenniumgoals/
40. Roll Back Malaria, Global Malaria Action Plan: For a malaria-free world Geneva: Roll Back Malaria 2008
41. Greenwood BM: Control to elimination: implications for malaria research. Trends Parasitol 2008, 24:449-454.